What is the recommended treatment for urinary tract infections (UTIs) in pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of UTIs in Pregnancy

First-line antibiotics for UTI treatment in pregnancy include nitrofurantoin, fosfomycin, and cephalexin, which provide effective treatment while maintaining safety for both mother and fetus. 1

Diagnosis and Screening

  • Screen all pregnant women for asymptomatic bacteriuria by urine culture at least once in early pregnancy 1
  • Obtain urine culture before starting antibiotics to confirm the causative pathogen and determine susceptibility 1
  • Unlike in non-pregnant women, asymptomatic bacteriuria in pregnancy requires treatment to prevent complications 2, 1

First-Line Treatment Options

For Uncomplicated UTIs in Pregnancy:

Antibiotic Dosing Duration Notes
Nitrofurantoin 100 mg twice daily 5-7 days Avoid after 36 weeks due to risk of neonatal hemolytic anemia [1]
Fosfomycin trometamol 3 g single dose One-time dose Convenient dosing with good safety profile [2,1]
Cephalexin 500 mg four times daily 5-7 days High safety profile with low resistance rates [1]

For Symptomatic UTI:

  • 5-7 days of therapy is generally recommended, as single-dose therapy (except for fosfomycin) and 3-day regimens may be insufficient for complete resolution 1

Alternative Option:

  • Amoxicillin-clavulanic acid: 500/125 mg three times daily for 5-7 days (recommended by WHO when first-line agents are contraindicated) 1

Important Precautions

  • Avoid trimethoprim-sulfamethoxazole (TMP-SMX) in the first trimester due to potential teratogenic effects and in the third trimester due to risk of neonatal hyperbilirubinemia 1
  • Adjust therapy based on culture results to ensure effective treatment and minimize resistance development 1
  • Consider local resistance patterns when selecting empiric therapy 1

Follow-up and Prevention

  • Repeat urine culture 1 week after completing therapy to confirm cure 1
  • For recurrent UTIs, consider prophylaxis with:
    • Nitrofurantoin 50-100 mg daily (avoid near term)
    • Cephalexin 250 mg post-coital dose 1

Management of Different UTI Types

Asymptomatic Bacteriuria

  • Must be treated in pregnancy (unlike non-pregnant women) 2, 1
  • Increases risk of pyelonephritis, preterm birth, and low birth weight if untreated 1, 3
  • Use standard treatment regimens as for symptomatic UTI 1

Pyelonephritis

  • Requires hospitalization and intravenous antibiotics 4
  • Preferred options include amoxicillin with an aminoglycoside, third-generation cephalosporins, or carbapenems 3

Behavioral Modifications

  • Recommend adequate hydration
  • Voiding after intercourse
  • Avoiding prolonged urine retention 1

UTIs affect up to 10% of pregnant women and are the second most common ailment of pregnancy after anemia 5. Proper treatment is essential as all forms of UTI during pregnancy can lead to serious maternal and fetal complications, making this a critical condition requiring prompt and appropriate management.

References

Guideline

Urinary Tract Infections in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Urinary tract infections in pregnancy.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.